Frontiers in neurology · 2025
Comparison of repetitive transcranial magnetic stimulation and intermittent theta burst stimulation efficacy in treating post-stroke dysphagia: a prospective, single-blind, randomized controlled study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Li Fang, Cheng Jinling, Zhu Yanying, Peng Yang, Liu Zicai
Аннотация
OBJECTIVE: To compare the efficacy of repetitive transcranial magnetic stimulation (rTMS) and intermittent theta burst stimulation (iTBS) applied to the motor cortex representation of the mylohyoid muscle in treating post-stroke dysphagia.
METHODS: Ninety-two patients with post-stroke dysphagia (July 2022-May 2023) were randomized into three groups: rTMS (n = 31), iTBS (n = 30), and control (n = 31). The rTMS and iTBS groups received respective stimulations plus routine rehabilitation; the control group received routine rehabilitation alone. Swallowing function was assessed pre- and post-intervention using the Penetration-Aspiration Scale (PAS) and Dysphagia Disability Index (DD).
RESULTS: After 2 weeks, all groups showed significant swallowing improvement (p < 0.001). Both rTMS and iTBS groups demonstrated greater improvement in PAS and DD scores versus controls (p < 0.001). No significant difference emerged between rTMS and iTBS efficacy (p > 0.05).
CONCLUSION: rTMS and iTBS equivalently improve post-stroke dysphagia. iTBS achieves comparable outcomes with shorter treatment duration, supporting its clinical adoption.
CLINICAL TRIAL REGISTRATION: Identifier ChiCTR2200058246, https://www.chictr.org.cn/.
METHODS: Ninety-two patients with post-stroke dysphagia (July 2022-May 2023) were randomized into three groups: rTMS (n = 31), iTBS (n = 30), and control (n = 31). The rTMS and iTBS groups received respective stimulations plus routine rehabilitation; the control group received routine rehabilitation alone. Swallowing function was assessed pre- and post-intervention using the Penetration-Aspiration Scale (PAS) and Dysphagia Disability Index (DD).
RESULTS: After 2 weeks, all groups showed significant swallowing improvement (p < 0.001). Both rTMS and iTBS groups demonstrated greater improvement in PAS and DD scores versus controls (p < 0.001). No significant difference emerged between rTMS and iTBS efficacy (p > 0.05).
CONCLUSION: rTMS and iTBS equivalently improve post-stroke dysphagia. iTBS achieves comparable outcomes with shorter treatment duration, supporting its clinical adoption.
CLINICAL TRIAL REGISTRATION: Identifier ChiCTR2200058246, https://www.chictr.org.cn/.